Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS

Autoimmune disorders of the central nervous system (CNS) comprise a broad spectrum of clinical entities. The stratification of patients based on the recognized autoantigen is of great importance for therapy optimization and for concepts of pathogenicity, but for most of these patients, the actual ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerhards, Ramona, Pfeffer, Lena Kristina, Lorenz, Jessica, Starost, Laura, Nowack, Luise, Thaler, Franziska S., Schlüter, Miriam, Rübsamen, Heike, Macrini, Caterina, Winklmeier, Stephan, Mader, Simone, Bronge, Mattias, Grönlund, Hans, Feederle, Regina, Hsia, Hung-En, Lichtenthaler, Stefan F., Merl-Pham, Juliane, Hauck, Stefanie M., Kuhlmann, Tanja, Bauer, Isabel J., Beltran, Eduardo, Gerdes, Lisa Ann, Mezydlo, Aleksandra, Bar-Or, Amit, Banwell, Brenda, Khademi, Mohsen, Olsson, Tomas, Hohlfeld, Reinhard, Lassmann, Hans, Kümpfel, Tania, Kawakami, Naoto, Meinl, Edgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706210/
https://www.ncbi.nlm.nih.gov/pubmed/33256847
http://dx.doi.org/10.1186/s40478-020-01086-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706210/
https://www.ncbi.nlm.nih.gov/pubmed/33256847
http://dx.doi.org/10.1186/s40478-020-01086-2

Ejemplares similares